FDA Adverse Event Injury Summary report: N

NEUROSTAR ADVANCED THERAPY

MDR report key: 21081607 · Received January 6, 2025

Report

Report Number
3004824012-2025-00001
Event Type
Injury
Date Received
January 6, 2025
Date of Event
November 6, 2024
Report Date
January 6, 2025
Manufacturer
NEURONETICS, INC.
Product Code
OBP
UDI-DI
00869378000117
PMA / PMN Number
K161519
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NC, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

THE MEDWATCH REPORT INCLUDED THE PATIENT NAME AND CONTACT INFORMATION ENABLING NEURONETICS TO FOLLOW UP WITH THE PATIENT AND THE PROVIDER. PATIENT'S PHQ-9 DEPRESSION SCORE IMPROVED AFTER THE 36 TREATMENTS. THE PROVIDER COULD NOT CORROBORATE ALL THE ALLEGATIONS MADE BY THE PATIENT. PATIENT RECORD INCLUDED DISCOMFORT AND NUMBNESS IN THE RIGHT FOREARM WHICH WENT AWAY. THERE IS NO EVIDENCE TO DETERMINE IF THE PATIENT'S HEALTH COMPLAINTS ARE DUE TO TMS TREATMENT OR A PROGRESSION OF OTHER MENTAL HEALTH ISSUES (SEVERE GAD, BIPOLAR II AND/OR BORDERLINE PERSONALITY DISORDER) WHICH ARE NOT CURRENTLY CLEARED FOR TMS TREATMENT.

Description of Event or Problem · 0

NEURONETICS RECEIVED MEDWATCH (MW) 5162644 FROM FDA VIA EMAIL ON DECEMBER 9, 2024. IN THE MW A FEMALE PATIENT ALLEGES EMOTIONAL CHANGES AFTER RECEIVING NEUROSTAR TMS TREATMENT. THESE EMOTIONAL CHANGES INCLUDE PARANOIA, ANXIETY, AND FEELING OF ANNOYANCE AND ANGER ALL THE TIME. SHE ALSO ALLEGES FEELING OF "BUGS CRAWLING ON HER SKIN", CONSTANT HEADACHES AND PAINFUL RIGHT HAND AND FOREARM.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
962489 NEUROSTAR ADVANCED THERAPY TRANSCRANIAL MAGNETIC STIMULATION OBP NEURONETICS, INC. NEUROSTAR 3.0 NA 00869378000117

Patients

Seq Age Sex Outcome Treatment
1 23 YR Female Other AUVELITY| B12| BENADRYL| CYMBALTA| IRON| METFORMIN| TOPROL XL| TYLENOL